189916 Analysis of the barriers to breast cancer screening in an HMO population in San Diego including a segmentation by stage of change, ethnicity, and region of San Diego county

Monday, October 27, 2008

Sandra R. Parkington, MPH, RN , HealthTrax, LLC, San Diego, CA
In the summer of 2007, Sharp Health Plan in San Diego, CA conducted a breast cancer screening barrier analysis study. The decision to perform a barrier analysis arose after the completion of an intervention in 2006 of two waves of reminder postcards with an appointment tracker format were followed by automated reminder phone calls; resulting in approximately 70% of the members receiving their screening mammograms. In this study, we attempted to reach over 700 non-compliant members aged 52 – 69 years who were eligible yet who had not received screening mammography in the prior 2 years. Personal phone calls to non-compliant members were performed using a survey which asked about recall of the intervention, determined the stage of change of the member, and assessed the barriers for mammography. We also asked the member's race and ethnicity if not already in the database.

Learning Objectives:
Learning Objectives: At the conclusion of the session, the participant (learner) in this session will be able to: Describe an approach for determining barriers to compliance with preventive screening mammography in a managed care population. Discuss lessons learned from the barrier analysis using a stage of change analysis and segmentations. Identify future intervention opportunities based on barrier analysis.

Keywords: Breast Cancer Screening, Health Care Quality

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: As the Quality Improvement Coordinator of Sharp Health Plan, I was responsible for designing, implementing, and analyzing the breast cancer screening barrier analysis with oversight by the Chief Medical Officer.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.